Estrogen Management on TRT: When to Treat, When to Leave Alone
Aromatase inhibitors are overprescribed in TRT. Here's the evidence on when estradiol actually needs to come down and when it's healthier to leave it alone.
One of the most common mistakes in modern TRT practice is aggressive estrogen suppression. Estradiol is not a side effect to be eliminated — it is an essential hormone in men, with critical roles in bone health, lipid metabolism, cognition, and sexual function.
Why estradiol rises on TRT
Aromatase, present in adipose tissue and other peripheral sites, converts testosterone to estradiol. As testosterone levels rise on therapy, estradiol rises proportionally. This is normal and expected.
What's a healthy estradiol level
There is no single perfect number, but most published reference ranges place healthy adult male estradiol between 20–40 pg/mL by ultrasensitive LC-MS assay. Symptoms — not the number alone — guide treatment.
When to act
True estrogen excess symptoms include water retention, breast tissue tenderness or development (gynecomastia), and emotional lability. These warrant evaluation. Treating an asymptomatic estradiol level of 45 because it's "high" is rarely warranted.
Why aggressive AI use causes harm
Aromatase inhibitors like anastrozole, when used aggressively, drive estradiol too low. The result: joint pain, low libido (counterintuitive but well-documented), accelerated bone loss, worsened lipid profile, and depressive symptoms. We see this pattern routinely in patients transferring from clinics with overly aggressive E2 management.
The Valora approach
We treat the patient, not the number. Symptomatic estrogen excess on labs that confirm it gets addressed with weight loss first, low-dose anastrozole second, and only in patients where lifestyle modification is insufficient. Routine anastrozole prescription with every TRT script is not evidence-based practice.
Sources & references
Peer-reviewed studies, clinical guidelines, and regulatory documents used to write this article.
- 1.Finkelstein JS et al. Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men. N Engl J Med. 2013;369:1011-1022.— New England Journal of Medicine, 2013.
- 2.Russell N, Grossmann M. Estradiol as a Male Hormone. Eur J Endocrinol. 2019;181:R23-R43.— European Journal of Endocrinology, 2019.
- 3.Mulhall JP et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200:423-432.— American Urological Association, 2018.
How this article was written: Researched and drafted by the Valora Rx editorial team using current peer-reviewed literature and clinical practice guidelines from bodies including the Endocrine Society, AUA, NAMS, ACOG, and FDA. This article is informational and is not a substitute for individualized medical advice from your physician. Read our editorial standards →
